X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BVXV

Closed

Biondvax Pharmaceuticals Ltd Adr

0.69
+0.05 (+7.81%)
Last Update: 08 Nov 2023 17:30:00
Yesterday: 0.64
Day's Range: 0.6201 - 0.6998
Send
When Written:
 
2.16
BiondVax Pharmaceuticals Ltd ADR is a biopharmaceutical company focused on developing universal flu vaccines. The company's lead product candidate, M-001, is designed to provide broad protection against various influenza strains, including both seasonal and pandemic flu. BiondVax's technology is based on a proprietary platform that utilizes a combination of conserved and variable influenza virus antigens to stimulate the immune system. The company is headquartered in Jerusalem, Israel, and its shares trade on the NASDAQ under the ticker symbol BVXV. As of August 2021, BiondVax Pharmaceuticals had a market capitalization of approximately $35 million.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X